Dexamethasone

• 

  Subject Areas on Research

  • A Phase II Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma. 
  • A Pseudomonas syringae type III effector suppresses cell wall-based extracellular defense in susceptible Arabidopsis plants. 
  • A comparison of the combination of aprepitant and dexamethasone versus the combination of ondansetron and dexamethasone for the prevention of postoperative nausea and vomiting in patients undergoing craniotomy. 
  • A comparison of the cortisol suppression index and the dexamethasone suppression test. 
  • A randomized double blind study to evaluate efficacy of palonosetron with dexamethasone versus palonosetron alone for prevention of postoperative and postdischarge nausea and vomiting in subjects undergoing laparoscopic surgeries with high emetogenic risk. 
  • A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. 
  • A randomized, double-blind study of granisetron plus dexamethasone versus ondansetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing abdominal hysterectomy. 
  • A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Ménière's disease. 
  • A sensitive, outpatient dexamethasone suppression test. 
  • A tissue-engineered human trabecular meshwork hydrogel for advanced glaucoma disease modeling. 
  • ABC Transporter Inhibition Plus Dexamethasone Enhances the Efficacy of Convection Enhanced Delivery in H3.3K27M Mutant Diffuse Intrinsic Pontine Glioma. 
  • AML-262 Pivekimab Sunirine (PVEK, IMGN632) Triplet With Azacitidine and Venetoclax Shows Broad Activity in Adverse Genetic Subsets of Relapsed/Refractory Acute Myeloid Leukemia and Reduced Infusion-Related Reactions. 
  • Abnormal cortisol suppression in bipolar patients with simultaneous manic and depressive symptoms. 
  • Acrylamide-regulated neurofilament expression in rat pheochromocytoma cells. 
  • Activation of the 9E3/cCAF chemokine by phorbol esters occurs via multiple signal transduction pathways that converge to MEK1/ERK2 and activate the Elk1 transcription factor. 
  • Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme. 
  • Additive and synergistic effects of fetal nicotine and dexamethasone exposure on cholinergic synaptic function in adolescence and adulthood: Implications for the adverse consequences of maternal smoking and pharmacotherapy of preterm delivery. 
  • Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice. 
  • Adrenal gland enlargement in major depression. A computed tomographic study. 
  • Adrenocortical sensitivity to low-dose ACTH administration in depressed patients. 
  • Adverse benzo[a]pyrene effects on neurodifferentiation are altered by other neurotoxicant coexposures: interactions with dexamethasone, chlorpyrifos, or nicotine in PC12 cells. 
  • Adverse neurodevelopmental effects of dexamethasone modeled in PC12 cells: identifying the critical stages and concentration thresholds for the targeting of cell acquisition, differentiation and viability. 
  • After 62 years of regulating immunity, dexamethasone meets COVID-19. 
  • Aging and glucocorticoids: effects on cell signaling mediated through adenylyl cyclase. 
  • Alprazolam vs amitriptyline in depressions with reduced REM latencies. 
  • An intravitreal device providing sustained release of cyclosporine and dexamethasone. 
  • Antiemetics: American Society of Clinical Oncology clinical practice guideline update. 
  • Apoptotic nuclease assays. 
  • Arecoline reverses dexamethasone suppression of cortisol in normal males: a pilot study. 
  • Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants. 
  • Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. 
  • Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial. 
  • Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial. 
  • Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma. 
  • Best practices for treatment of retinal vein occlusion. 
  • Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. 
  • Bombesin-like peptide and receptors in lung injury models: diverse gene expression, similar function. 
  • Bombesin-like peptide receptor gene expression, regulation, and function in fetal murine lung. 
  • Bombesin-like peptides and receptors in normal fetal baboon lung: roles in lung growth and maturation. 
  • Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study. 
  • C4 article: Implications of COVID-19 in transplantation. 
  • COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial. 
  • Cancer recurrence and hyperglycemia with dexamethasone for postoperative nausea and vomiting prophylaxis: more moot points? 
  • Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma. 
  • Characterization of porous, dexamethasone-releasing polyurethane coatings for glucose sensors. 
  • Characterizing differences between MSCs and TM cells: Toward autologous stem cell therapies for the glaucomatous trabecular meshwork. 
  • Chronic pain and depression. 
  • Chronic pain and depression. IV. DST as a discriminator between chronic pain and depression. 
  • Clinical Decision Making and Visual Outcomes in Endophthalmitis Treated with Systemic Corticosteroids. 
  • Clinical trial of focal segmental glomerulosclerosis in children and young adults. 
  • Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. 
  • Clustering gene expression time series data using an infinite Gaussian process mixture model. 
  • Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. 
  • Comparison of in vitro and in vivo differentiation of myeloblastic leukemia of the RFM/Un mouse. 
  • Comparison of serial PET and MRI scans in a pediatric patient with a brainstem glioma. 
  • Conservation of hearing and protection of auditory hair cells against trauma-induced losses by local dexamethasone therapy: molecular and genetic mechanisms. 
  • Control of adenylate cyclase activity in developing rat heart and liver: effects of prenatal exposure to terbutaline or dexamethasone. 
  • Controversies in the Management of Isolated Congenital Atrioventricular Block. 
  • Convergent control of serotonin transporter expression by glucocorticoids and cocaine in fetal and neonatal rat brain. 
  • Coronary constriction to angiotensin II is enhanced by endothelial superoxide production in sheep programmed by dexamethasone. 
  • Cortico-cortical projections in mouse visual cortex are functionally target specific. 
  • Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. 
  • Corticosteroids for HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome. 
  • Critical prenatal and postnatal periods for persistent effects of dexamethasone on serotonergic and dopaminergic systems. 
  • Cryptococcal meningitis in patients with glioma: a report of two cases. 
  • Cytoskeletal dependence of adenosine triphosphate release by human trabecular meshwork cells. 
  • Delineation of the signaling pathways involved in glucocorticoid-induced and spontaneous apoptosis of rat thymocytes. 
  • Depression and dexamethasone suppression testing in children and adolescents. 
  • Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. 
  • Depression in early-onset Alzheimer's disease: clinical and neuroendocrine correlates. 
  • Depression spectrum disease with and without depression in first-degree relatives. 
  • Development of glucocorticoid receptor regulation in the rat forebrain: implications for adverse effects of glucocorticoids in preterm infants. 
  • Development of polyamine and biogenic amine systems in brains and hearts of neonatal rats given dexamethasone: role of biochemical alterations in cellular maturation for producing deficits in ontogeny of neurotransmitter levels, uptake, storage and turnover. 
  • Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. 
  • Developmental neurotoxicity resulting from pharmacotherapy of preterm labor, modeled in vitro: Terbutaline and dexamethasone, separately and together. 
  • Developmental neurotoxicity targeting hepatic and cardiac sympathetic innervation: effects of organophosphates are distinct from those of glucocorticoids. 
  • Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. 
  • Dexamethasone for Inpatients With COVID-19 in a National Cohort. 
  • Dexamethasone for the prophylaxis of postoperative nausea and vomiting associated with neuraxial morphine administration: a systematic review and meta-analysis. 
  • Dexamethasone increases adult rat lung surfactant lipids. 
  • Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study. 
  • Dexamethasone potentiates in vitro blood-brain barrier recovery after primary blast injury by glucocorticoid receptor-mediated upregulation of ZO-1 tight junction protein. 
  • Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. 
  • Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. 
  • Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression. 
  • Dexamethasone suppresses DU145 cell proliferation and cell cycle through inhibition of the extracellular signal-regulated kinase 1/2 pathway and cyclin D1 expression. 
  • Dexamethasone suppression test and onset of poststroke depression in patients with ischemic infarction. 
  • Dexamethasone suppression test identifies a subset of elderly depressed patients with reduced platelet serotonin transport and resistance to imipramine inhibition of transport. 
  • Dexamethasone suppression test status does not predict differential response to nortriptyline versus amitriptyline. 
  • Dexamethasone sustained drug delivery implant for the treatment of severe uveitis. 
  • Dexamethasone treatment in utero enhances neonatal cholinergic nerve terminal development in rat brain. 
  • Dexamethasone, blood glucose and CONSORT guidelines - a reply. 
  • Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes. 
  • Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy. 
  • Diagnosis and neuroanatomical correlates of depression in brain-damaged patients. Implications for a neurology of depression. 
  • Diagnostic utility of the dexamethasone suppression test. 
  • Differential modulation of gene induction by glucocorticoids and antiglucocorticoids in rat hepatoma tissue culture cells. 
  • Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells. 
  • Differential sensitivity to dexamethasone suppression in an animal model of the DST. 
  • Differentiating primary affective disease, organic affective syndromes, and situational depression on a pediatric service. 
  • Differentiation of depression from chronic pain with the dexamethasone suppression test and DSM-III. 
  • Direct GR Binding Sites Potentiate Clusters of TF Binding across the Human Genome. 
  • Direct effects of corticotropin-releasing hormone and thyrotropin-releasing hormone on fetal lung explants. 
  • Disruption of Mekk2 in mice reveals an unexpected role for MEKK2 in modulating T-cell receptor signal transduction. 
  • Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation. 
  • Diverse neurotoxicants target the differentiation of embryonic neural stem cells into neuronal and glial phenotypes. 
  • Do glucocorticoids contribute to the abnormalities in serotonin transporter expression and function seen in depression? An animal model. 
  • Does growth impairment underlie the adverse effects of dexamethasone on development of noradrenergic systems? 
  • Dose-dependent effect of prenatal dexamethasone treatment on beta-adrenergic receptor coupling to ornithine decarboxylase and cyclic AMP. 
  • Dose-dependent glucocorticoid effects on noradrenergic synaptogenesis in rat brain: ontogeny of [3H]desmethylimipramine binding sites after fetal exposure to dexamethasone. 
  • Early gestation dexamethasone programs enhanced postnatal ovine coronary artery vascular reactivity. 
  • Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial. 
  • Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. 
  • Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. 
  • Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect® MM Registry. 
  • Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. 
  • Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. 
  • Effects of Single Low Dose of Dexamethasone before Noncardiac and Nonneurologic Surgery and General Anesthesia on Postoperative Cognitive Dysfunction-A Phase III Double Blind, Randomized Clinical Trial. 
  • Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier. 
  • Effects of aging and glucocorticoid treatment on monoamine oxidase subtypes in rat cerebral cortex: therapeutic implications. 
  • Effects of dexamethasone on the contractile function of reperfused skeletal muscle. 
  • Effects of fetal dexamethasone exposure on postnatal control of cardiac adenylate cyclase: beta-adrenergic receptor coupling to Gs regulatory protein. 
  • Effects of prenatal dexamethasone on development of ornithine decarboxylase activity in brain and peripheral tissues of rats. 
  • Effects of prenatal dexamethasone or terbutaline exposure on development of neural and intrinsic control of heart rate. 
  • Effects of progesterone and estradiol sex hormones on the release of microparticles by RAW 264.7 macrophages stimulated by Poly(I:C). 
  • Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase-Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized Clinical Trial. 
  • Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149. 
  • Elevated cerebrospinal fluid cytokine levels in tuberculous meningitis predict survival in response to dexamethasone. 
  • Elevated plasma concentrations of alpha 1-acid glycoprotein, a putative endogenous inhibitor of the tritiated imipramine binding site, in depressed patients. 
  • Employing Macrophage-Derived Microvesicle for Kidney-Targeted Delivery of Dexamethasone: An Efficient Therapeutic Strategy against Renal Inflammation and Fibrosis. 
  • Endothelial superoxide production is altered in sheep programmed by early gestation dexamethasone exposure. 
  • Enhanced cortisol suppression following dexamethasone administration in domestic violence survivors. 
  • Epidermolysis bullosa hereditaria letalis: pathology, natural history and therapy. 
  • Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. 
  • Expression of a constitutive form of calcium/calmodulin dependent protein kinase II leads to arrest of the cell cycle in G2. 
  • Expression of mRNA coding for the serotonin transporter in aged vs. young rat brain: differential effects of glucocorticoids. 
  • Fetal dexamethasone exposure accelerates development of renal function: relationship to dose, cell differentiation and growth inhibition. 
  • Fetal dexamethasone exposure affects basal ornithine decarboxylase activity in developing rat brain regions and alters acute responses to hypoxia and maternal separation. 
  • Fetal dexamethasone exposure alters macromolecular characteristics of rat brain development: a critical period for regionally selective alterations? 
  • Fetal dexamethasone exposure impairs cellular development in neonatal rat heart and kidney: effects on DNA and protein in whole tissues. 
  • Fetal dexamethasone exposure interferes with establishment of cardiac noradrenergic innervation and sympathetic activity. 
  • Fetal dexamethasone exposure sensitizes neonatal rat brain to hypoxia: effects on protein and DNA synthesis. 
  • Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma. 
  • Gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, insights, and a proposed approach. 
  • Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. 
  • Gestational dexamethasone treatment elicits sex-dependent alterations in locomotor activity, reward-based memory and hippocampal cholinergic function in adolescent and adult rats. 
  • Glucocorticoid administration alters nuclear transcription factors in fetal rat brain: implications for the use of antenatal steroids. 
  • Glucocorticoid receptor binding to rat liver nuclei occurs without nuclear transport. 
  • Glucocorticoid therapy in sepsis/shock caused by gram-negative microorganisms. 
  • Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. 
  • Glucocorticoid-induced thymocyte apoptosis: protease-dependent activation of cell shrinkage and DNA degradation. 
  • Glucocorticoid-targeting of the adenylyl cyclase signaling pathway in the cerebellum of young vs. aged rats. 
  • Glucocorticoids accelerate the ontogenetic transition of cardiac ventricular myosin heavy-chain isoform expression in the rat: promotion by prenatal exposure to a low dose of dexamethasone. 
  • Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms. 
  • Glucocorticoids and the development of neuronal function: effects of prenatal dexamethasone exposure on central noradrenergic activity. 
  • Glucocorticoids enhance intracellular signaling via adenylate cyclase at three distinct loci in the fetus: a mechanism for heterologous teratogenic sensitization? 
  • Glucocorticoids manifest androgenic activity in a cell line derived from a metastatic prostate cancer. 
  • Glucocorticoids regulate the development of intracellular signaling: enhanced forebrain adenylate cyclase catalytic subunit activity after fetal dexamethasone exposure. 
  • Glucocorticosteroid inhibition of intraocular proliferation after injury. 
  • Glypican-4 regulated actin cytoskeletal reorganization in glucocorticoid treated trabecular meshwork cells and involvement of Wnt/PCP signaling. 
  • HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. 
  • Histochemical analyses of altered fetal lung development following single vs multiple courses of antenatal steroids. 
  • Hormonal control of angiotensinogen production. 
  • How do I provide leukapheresis products? Blood center experience and evidence for process improvement. 
  • Hypercortisolemia and hippocampal changes in depression. 
  • Hypercortisolism associated with social subordinance or social isolation among wild baboons. 
  • Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. 
  • Impact of perioperative dexamethasone on postoperative analgesia and side-effects: systematic review and meta-analysis. 
  • Impact of postoperative nausea and vomiting prophylaxis with dexamethasone on the risk of recurrence of endometrial cancer. 
  • In vitro and in vivo genotoxicity evaluation of hormonal drugs. II. Dexamethasone. 
  • In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings. 
  • In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. 
  • Increased hypothalamic [3H]flunitrazepam binding in hypothalamic-pituitary-adrenal axis hyporesponsive Lewis rats. 
  • Index of suspicion. 
  • Induction and suppression of PEN3 focal accumulation during Pseudomonas syringae pv. tomato DC3000 infection of Arabidopsis. 
  • Induction of protein secretory pathway is required for systemic acquired resistance. 
  • Inhibiting cortisol response accelerates recovery from a photic phase shift. 
  • Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. 
  • Inhibition of epidural scar formation after lumbar laminectomy in the rat. 
  • Inhibition of microglial superoxide anion production by isoproterenol and dexamethasone. 
  • Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) messenger RNA (mRNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethasone: dissociation of acivicin-induced TNF-alpha and IL-1 beta mRNA expression from acivicin-induced monocytoid differentiation. 
  • Insulin inhibits dexamethasone effect on angiotensinogen gene expression and induction of hypertrophy in rat kidney proximal tubular cells in high glucose. 
  • Intracanalicular Dexamethasone Insert or Topical Prednisolone Following iStent and Hydrus Surgery for Glaucoma. 
  • Intracellular K+ suppresses the activation of apoptosis in lymphocytes. 
  • Intratympanic Therapies in Ménière Disease: Evaluation of Outcomes and Early Vertigo Control. 
  • Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. 
  • Intravenous Migraine Treatment in Children and Adolescents. 
  • Intravitreal Pharmacotherapies for Diabetic Macular Edema: A Report by the American Academy of Ophthalmology. 
  • Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy. 
  • Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis. 
  • Investigation of the mechanisms contributing to the compensatory increase in insulin secretion during dexamethasone-induced insulin resistance in rhesus macaques. 
  • Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial. 
  • Isolated IgA deficiency after chemotherapy for acute myelogenous leukemia in an infant. 
  • L-N-Acetylcysteine treatment is associated with improved hearing outcome in sudden idiopathic sensorineural hearing loss. 
  • Lactogenic and somatogenic hormones regulate the expression of neuropeptide Y and cocaine- and amphetamine-regulated transcript in rat insulinoma (INS-1) cells: interactions with glucose and glucocorticoids. 
  • Lasting effects of developmental dexamethasone treatment on neural cell number and size, synaptic activity, and cell signaling: critical periods of vulnerability, dose-effect relationships, regional targets, and sex selectivity. 
  • Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer. 
  • Local drug delivery to conserve hearing: mechanisms of action of eluted dexamethasone within the cochlea. 
  • Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine. A placebo-controlled study. 
  • Management of postdischarge nausea and vomiting after ambulatory surgery. 
  • Management of tumor bed cysts after chemotherapeutic wafer implantation. Report of four cases. 
  • Manganese porphyrin, MnTE-2-PyP5+, Acts as a pro-oxidant to potentiate glucocorticoid-induced apoptosis in lymphoma cells. 
  • Maturation of sympathetic neurotransmission in the rat heart. VII. Suppression of sympathetic responses by dexamethasone. 
  • Mechanism of Fibronectin Binding to Human Trabecular Meshwork Exosomes and Its Modulation by Dexamethasone. 
  • Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL. 
  • Melancholic symptom features and DSM-IV. 
  • Mimicking maternal smoking and pharmacotherapy of preterm labor: fetal nicotine exposure enhances the effect of late gestational dexamethasone treatment on noradrenergic circuits. 
  • Mimicking maternal smoking and pharmacotherapy of preterm labor: interactions of fetal nicotine and dexamethasone on serotonin and dopamine synaptic function in adolescence and adulthood. 
  • Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia. 
  • Multi-agent chemotherapy overcomes glucocorticoid resistance conferred by a BIM deletion polymorphism in pediatric acute lymphoblastic leukemia. 
  • Multiple myeloma, version 1.2013. 
  • Multi‑organ assessment via a 9.4‑Tesla MRS evaluation of metabolites during the embryonic development of cleft palate induced by dexamethasone. 
  • National Utilization and Forecasting of Ototopical Antibiotics: Medicaid Data Versus "Dr. Google". 
  • Neonatal dexamethasone treatment leads to alterations in cell signaling cascades controlling hepatic and cardiac function in adulthood. 
  • Neuroanatomical changes and hypothalamo-pituitary-adrenal axis abnormalities. 
  • New Insight of Common Regulatory Pathways in Human Trabecular Meshwork Cells in Response to Dexamethasone and Prednisolone Using an Integrated Quantitative Proteomics: SWATH and MRM-HR Mass Spectrometry. 
  • New concepts in the diagnosis and management of depression. 
  • Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of CCAAT/enhancer-binding protein β during adipogenesis. 
  • Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients. 
  • Ontogeny of mu- and kappa-opiate receptor control of the hypothalamo-pituitary-adrenal axis in rats. 
  • Open-Label Clinical Trials of Oral Pulse Dexamethasone for Adults with Idiopathic Nephrotic Syndrome. 
  • Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH. 
  • Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA. 
  • PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma. 
  • Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study. 
  • Pentablock copolymer dexamethasone nanoformulations elevate MYOC: in vitro liberation, activity and safety in human trabecular meshwork cells. 
  • Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial. 
  • Perioperative Dexamethasone Administration Does Not Increase the Incidence of Postoperative Infection in Total Hip and Knee Arthroplasty: A Retrospective Analysis. 
  • Perioperative Glucocorticoid Administration Improves Elbow Motion in Terrible Triad Injuries. 
  • Persistent cortisol non-suppression after clinical recovery predicts symptomatic relapse in unipolar depression. 
  • Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma. 
  • Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001). 
  • Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma. 
  • Phase II study of docetaxel in advanced soft tissue sarcomas. 
  • Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy. 
  • Phase II study of dose-attenuated bortezomib, cyclophosphamide and dexamethasone ("VCD-Lite") in very old or otherwise toxicity-vulnerable adults with newly diagnosed multiple myeloma. 
  • Phosphatidic acid phosphatase in neonatal rat lung: effects of prenatal dexamethasone or terbutaline treatment on basal activity and on responsiveness to beta adrenergic stimulation. 
  • Photocoagulation and local steroid-induced ocular hypertension in the treatment of diabetic retinopathy. 
  • Plasma dexamethasone concentrations and the dexamethasone suppression test. 
  • Polysomnographic findings and dexamethasone nonsuppression in unipolar depression: a replication and extension. 
  • Polysomnographic findings in recently drug-free and clinically remitted depressed patients. 
  • Porous, Dexamethasone-loaded polyurethane coatings extend performance window of implantable glucose sensors in vivo. 
  • Postoperative blood sugars and use of starches - a reply. 
  • Postoperative hyperglycemia after 4- vs 8-10-mg dexamethasone for postoperative nausea and vomiting prophylaxis in patients with type II diabetes mellitus: a retrospective database analysis. 
  • Preclinical Modeling of Surgery and Steroid Therapy for Glioblastoma Reveals Changes in Immunophenotype that are Associated with Tumor Growth and Outcome. 
  • Prenatal dexamethasone administration disrupts the pattern of cellular development in rat lung. 
  • Prenatal dexamethasone augments the neurobehavioral teratology of chlorpyrifos: significance for maternal stress and preterm labor. 
  • Prenatal dexamethasone augments the sex-selective developmental neurotoxicity of chlorpyrifos: implications for vulnerability after pharmacotherapy for preterm labor. 
  • Prenatal dexamethasone exposure causes loss of neonatal hypoxia tolerance: cellular mechanisms. 
  • Prenatal dexamethasone, as used in preterm labor, worsens the impact of postnatal chlorpyrifos exposure on serotonergic pathways. 
  • Prenatal drug exposures sensitize noradrenergic circuits to subsequent disruption by chlorpyrifos. 
  • Progesterone inhibits glucocorticoid-induced murine thymocyte apoptosis. 
  • Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up. 
  • Programming of brainstem serotonin transporter development by prenatal glucocorticoids. 
  • Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to beta-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. 
  • Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to beta-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. 
  • Protein profile of exosomes from trabecular meshwork cells. 
  • RU486 in depression. 
  • Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children's Oncology Group Studies P9904 and P9905. 
  • Reduced rapid eye movement latency. A predictor of recurrence in depression. 
  • Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials. 
  • Regulation of apoptosis in S49 cells. 
  • Regulation of brain ornithine decarboxylase activity in the neonatal rat. 
  • Regulation of connective tissue growth factor expression in the aqueous humor outflow pathway. 
  • Regulation of islet beta-cell pyruvate metabolism: interactions of prolactin, glucose, and dexamethasone. 
  • Regulation of myocilin-associated exosome release from human trabecular meshwork cells. 
  • Regulation of neonatal rat lung compliance by beta-adrenergic receptor stimulation: effects of prenatal exposure to terbutaline or dexamethasone. 
  • Regulation of postnatal beta-adrenergic receptor/adenylate cyclase development by prenatal agonist stimulation and steroids: alterations in rat kidney and lung after exposure to terbutaline or dexamethasone. 
  • Regulation of tyrosine hydroxylase mRNA by glucocorticoid and cyclic AMP in a rat pheochromocytoma cell line. Isolation of a cDNA clone for tyrosine hydroxylase mRNA. 
  • Regulation of tyrosine hydroxylase mRNA by glucocorticoid and cyclic AMP in a rat pheochromocytoma cell line. Isolation of a cDNA clone for tyrosine hydroxylase mRNA. 
  • Regulatory genes linked to the albino locus in the mouse confer competence for inducible expression on the structural gene encoding serine dehydratase. 
  • Relationship of dysfunctional attitudes and dexamethasone response in endogenous and nonendogenous depression. 
  • Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings. 
  • Repeated therapeutic lumbar punctures in cryptococcal meningitis - necessity and/or opportunity? 
  • Respiratory Support for Very Low Birth Weight Infants Receiving Dexamethasone. 
  • Response to isocarboxazid and the DST. 
  • Reversible bilateral optic tract edema following pipeline-assisted coiling of a large ophthalmic aneurysm: A case report. 
  • Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma. 
  • Risk Model-Guided Antiemetic Prophylaxis vs Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Randomized Clinical Trial. 
  • Role of cytochrome P4503A in cysteine S-conjugates sulfoxidation and the nephrotoxicity of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in rats. 
  • Role of serotonin in hypothalamo pituitary adrenal axis escape from dexamethasone suppression. 
  • Roles of cytoplasmic Ca2+ and intracellular Ca2+ stores in induction and suppression of apoptosis in S49 cells. 
  • Secondary agoraphobia: two case reports. 
  • Secondary depression: a comparison among subtypes. 
  • Selective loss of ornithine decarboxylase response to adrenergic agonists and glucagon during food deprivation of neonatal rats. 
  • Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma. 
  • Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects. 
  • Serum concentrations of deoxycorticosterone in women during the luteal phase of the ovarian cycle are not suppressed by dexamethasone treatment. 
  • Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorders. 
  • Snare protein expression and adenoviral transfection of amphicrine AR42J. 
  • Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism. 
  • Steroids in rhinoplasty. 
  • Successful management of orbital cellulitis and temporary visual loss after blepharoplasty. 
  • Suppression of cortisol following dexamethasone in demented patients. 
  • Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids. 
  • Surfactant apoprotein in adult rat lung compartments is increased by dexamethasone. 
  • Synergistic effect of dexamethasone and isoproterenol on the expression of angiotensinogen in immortalized rat proximal tubular cells. 
  • THE EFFECTS OF PERIOPERATIVE DEXAMETHASONE ON GLYCEMIC CONTROL AND POSTOPERATIVE OUTCOMES. 
  • TRH-induced prolactin release is blunted in females with endogenous unipolar major depression. 
  • Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. 
  • Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma. 
  • Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway Inflammation. 
  • Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial. 
  • The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway. 
  • The DST and posttraumatic stress disorder. 
  • The Effects of Dexamethasone in Diabetic Patients Undergoing Primary Total Joint Arthroplasty. 
  • The dexamethasone suppression test and quantitative cerebral anatomy in depression. 
  • The dexamethasone suppression test as a biologic marker of depression in chronic pain. 
  • The dexamethasone suppression test in borderline personality disorder. 
  • The dexamethasone suppression test in patients with mood disorders. 
  • The dissociation of catecholamine and hypothalamic-pituitary-adrenal responses to daily stressors using dexamethasone. 
  • The effect of angiostatic steroids and beta-cyclodextrin tetradecasulfate on corneal neovascularization in the rat. 
  • The effect of anti-emetic doses of dexamethasone on postoperative blood glucose levels in non-diabetic and diabetic patients: a prospective randomised controlled study. 
  • The effect of dexamethasone on the generation of plasma DNA from dead and dying cells. 
  • The effect of dosage on the dexamethasone suppression test in normal controls. 
  • The effects of aging, antiinflammatory drugs, and ultrasound on the in vitro response of tendon tissue. 
  • The effects of leukemosuppressive immunotherapy on bone marrow infectious cell centers in AKR mice. 
  • The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function. 
  • The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials. 
  • The evaluation of drug rechallenge: the casopitant Phase III program. 
  • The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer. 
  • The expression of plasma nucleosomes in mice undergoing in vivo apoptosis. 
  • The glucocorticoid hormone signal transduction pathway in mice homozygous for chromosomal deletions causing failure of cell type-specific inducible gene expression. 
  • The impact of postoperative nausea and vomiting prophylaxis with dexamethasone on postoperative wound complications in patients undergoing laparotomy for endometrial cancer. 
  • The interplay of prolactin and the glucocorticoids in the regulation of beta-cell gene expression, fatty acid oxidation, and glucose-stimulated insulin secretion: implications for carbohydrate metabolism in pregnancy. 
  • The natural history of retinal vein occlusion: what do we really know? 
  • The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. 
  • The relationship between outflow resistance and trabecular meshwork stiffness in mice. 
  • The response of depressed inpatients to isocarboxazid. 
  • The use of prophylactic eye drops during high-dose cytosine arabinoside therapy. 
  • The utility of the dexamethasone suppression test. 
  • Therapies for Macular Edema Associated with Branch Retinal Vein Occlusion: A Report by the American Academy of Ophthalmology. 
  • Therapy for ocular toxoplasmosis. 
  • Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. 
  • Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes. 
  • Topical conjunctival corticosteroid therapy for malignant atrophic papulosis (Kohlmeier-Degos disease). 
  • Transcriptional regulation of the tyrosine hydroxylase gene by glucocorticoid and cyclic AMP. 
  • Transient complete lower facial nerve palsy after craniotomy for aneurysm clipping. 
  • Transient lumbosacral polyradiculopathy after prostatectomy: association with spinal stenosis. 
  • Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results? 
  • Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry. 
  • Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes. 
  • Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma. 
  • Ulceration of Striae distensae in high-grade glioma patients on concurrent systemic corticosteroid and bevacizumab therapy. 
  • Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice. 
  • Unique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X. 
  • Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy. 
  • Using "old" medications to fight new COVID-19: Re-purposing with a purpose. 
  • Validation of four definitions of melancholia by the dexamethasone suppression test. 
  • Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings affect the foreign body response. 
  • Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial. 
  • Vertebrate Lonesome Kinase Regulated Extracellular Matrix Protein Phosphorylation, Cell Shape, and Adhesion in Trabecular Meshwork Cells. 
  • Virilization during pregnancy associated with polycystic ovary disease. 
  • Weight change and the dexamethasone suppression test. 
  • What does the dexamethasone suppression test identify? 
  • β-Glucan exacerbates allergic asthma independent of fungal sensitization and promotes steroid-resistant TH2/TH17 responses. 
• 

  Keywords of People

  • Driehuys, Bastiaan, Professor of Radiology, Biomedical Engineering
  • Fekrat, Sharon, Professor of Ophthalmology, Ophthalmology, Vitreoretinal Diseases & Surgery
  • Ferguson, P. Lee, Associate Professor of Civil and Environmental Engineering, Civil and Environmental Engineering
  • Freemark, Michael Scott, Robert C. Atkins, M.D. and Veronica Atkins Distinguished Professor of Pediatrics, in the School of Medicine, Pediatrics, Endocrinology
  • Hogan, Brigid L. M., Research Professor of Cell Biology, Cell Biology
  • Middleton, John Paul, Professor of Medicine, Medicine, Nephrology